Yichang Humanwell Company Profile
✉ Email this page to a colleague
What is the competitive landscape for YICHANG HUMANWELL
YICHANG HUMANWELL has twenty-five approved drugs.
Drugs and US Patents for Yichang Humanwell
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yichang Humanwell | IBUPROFEN | ibuprofen | TABLET;ORAL | 215318-003 | Mar 30, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Yichang Humanwell | DESVENLAFAXINE SUCCINATE | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 210014-002 | Oct 1, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Yichang Humanwell | FLECAINIDE ACETATE | flecainide acetate | TABLET;ORAL | 215599-002 | Sep 8, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Yichang Humanwell | POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 209314-002 | Jun 22, 2018 | AB2 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Yichang Humanwell | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 211347-003 | Oct 16, 2018 | AB1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Yichang Humanwell | FLECAINIDE ACETATE | flecainide acetate | TABLET;ORAL | 215599-001 | Sep 8, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

